Kelsall TS, DeBeck K, Cameron G, Gorbach P, Milloy MJ, Hayashi K Food insecurity during the COVID-19 pandemic among people who use drugs in Vancouver, Canada Public Health Nutr PubMed

Mok J, Milloy MJ, Grant C, Lake S, DeBeck K, Hayashi K, Kerr T, Socías ME Use of cannabis as a harm reduction strategy among people who use drugs: a cohort study Cannabis Cannabinoid Res PubMed

Ti L, Grant CJ, Tobias S, Hore DK, Laing R, Marshall BDL Development of a neural network model to predict the presence of fentanyl in community drug samples PLoS One PubMed

Pilarinos A, Bingham B, Kwa Y, Joe R, Grant C, Fast D, Buxton J, DeBeck K Interest in using buprenorphine-naloxone among a prospective cohort of street-involved young people in Vancouver, Canada J Subst Use Addict Treat PubMed

Pilarinos A, Kwa Y, Joe R, Dong H, Grant C, Fast D, Buxton J, DeBeck K Methadone maintenance treatment discontinuation among young people use who opioids in Vancouver, Canada Can J Psychiatry PubMed

Tobias S, Grant CJ, Laing R, Lysyshyn M, Buxton JA, Tupper KW, Wood E, Ti L What impact did the COVID-19 pandemic have on the variability of fentanyl concentrations in the Vancouver, Canada illicit drug supply? An interrupted time-series analysis BMJ Public Health Link

Stover S, Milloy MJ, Grant C, Fairbairn N, Socías ME Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs AIDS PubMed

Beaulac M, Richardson L, Tobias S, Lysyshyn M, Grant C, Ti L Changes in the unregulated opioid drug supply during income assistance payment weeks in Vancouver, Canada: an exploratory analysis Int J Drug Policy PubMed

Mitra S, Grant C, Nolan S, Mohd Salleh NA, Milloy MJ, Richardson L Assessing the temporality between transitions onto opioid agonist therapy and engagement with antiretroviral therapy in a cohort of HIV-positive people who use opioids daily AIDS Behav PubMed

Bach P, Bawa M, Grant C, Milloy MJ, Hayashi K Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014-2020 Int J Drug Policy PubMed